Katerina Kechris
Concepts (504)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pulmonary Disease, Chronic Obstructive | 21 | 2026 | 926 | 2.970 |
Why?
| | Metabolomics | 16 | 2024 | 737 | 2.750 |
Why?
| | DNA Methylation | 23 | 2026 | 721 | 2.610 |
Why?
| | Software | 14 | 2026 | 673 | 2.060 |
Why?
| | Algorithms | 14 | 2025 | 1843 | 2.040 |
Why?
| | Computational Biology | 9 | 2025 | 675 | 1.980 |
Why?
| | Genome-Wide Association Study | 11 | 2024 | 1526 | 1.940 |
Why?
| | Gene Expression Profiling | 21 | 2026 | 1790 | 1.780 |
Why?
| | Sequence Analysis, RNA | 9 | 2021 | 441 | 1.680 |
Why?
| | Proteomics | 5 | 2026 | 1202 | 1.660 |
Why?
| | Bayes Theorem | 10 | 2023 | 424 | 1.640 |
Why?
| | MicroRNAs | 11 | 2026 | 695 | 1.620 |
Why?
| | High-Throughput Nucleotide Sequencing | 5 | 2021 | 538 | 1.410 |
Why?
| | Mass Spectrometry | 6 | 2022 | 728 | 1.400 |
Why?
| | Genomics | 7 | 2025 | 851 | 1.330 |
Why?
| | Quantitative Trait Loci | 15 | 2024 | 388 | 1.280 |
Why?
| | Gene Regulatory Networks | 6 | 2025 | 319 | 1.230 |
Why?
| | Gene Expression Regulation | 13 | 2025 | 2591 | 1.200 |
Why?
| | Data Interpretation, Statistical | 5 | 2020 | 365 | 1.160 |
Why?
| | Smoking | 9 | 2025 | 1478 | 1.160 |
Why?
| | Prenatal Exposure Delayed Effects | 13 | 2025 | 662 | 1.110 |
Why?
| | Autoimmunity | 12 | 2026 | 924 | 1.090 |
Why?
| | Polymorphism, Single Nucleotide | 11 | 2024 | 2228 | 1.080 |
Why?
| | Models, Genetic | 7 | 2019 | 537 | 1.030 |
Why?
| | Islets of Langerhans | 9 | 2026 | 852 | 1.030 |
Why?
| | Phenotype | 21 | 2024 | 3186 | 0.940 |
Why?
| | Oligonucleotide Array Sequence Analysis | 6 | 2021 | 751 | 0.880 |
Why?
| | Adiposity | 10 | 2024 | 531 | 0.860 |
Why?
| | Diabetes Mellitus, Type 1 | 15 | 2026 | 3930 | 0.820 |
Why?
| | Gene Expression | 10 | 2021 | 1461 | 0.810 |
Why?
| | Brain | 9 | 2024 | 2981 | 0.790 |
Why?
| | Transcriptome | 10 | 2025 | 1066 | 0.760 |
Why?
| | Epigenesis, Genetic | 13 | 2026 | 705 | 0.740 |
Why?
| | Metabolome | 5 | 2024 | 390 | 0.720 |
Why?
| | Computer Simulation | 9 | 2025 | 1014 | 0.720 |
Why?
| | Databases, Factual | 6 | 2021 | 1481 | 0.700 |
Why?
| | Emphysema | 4 | 2023 | 100 | 0.690 |
Why?
| | Models, Statistical | 5 | 2020 | 667 | 0.670 |
Why?
| | Propensity Score | 1 | 2023 | 370 | 0.650 |
Why?
| | Ethanol | 5 | 2020 | 629 | 0.630 |
Why?
| | Maternal Exposure | 6 | 2024 | 189 | 0.630 |
Why?
| | Conserved Sequence | 3 | 2009 | 242 | 0.620 |
Why?
| | Humans | 102 | 2026 | 145625 | 0.610 |
Why?
| | Pediatric Obesity | 7 | 2024 | 635 | 0.610 |
Why?
| | Biomarkers | 21 | 2026 | 4329 | 0.600 |
Why?
| | Pulmonary Emphysema | 6 | 2023 | 276 | 0.600 |
Why?
| | User-Computer Interface | 1 | 2020 | 164 | 0.590 |
Why?
| | Machine Learning | 2 | 2024 | 590 | 0.590 |
Why?
| | Fluorocarbons | 4 | 2023 | 122 | 0.560 |
Why?
| | RNA | 4 | 2021 | 925 | 0.550 |
Why?
| | Fetal Blood | 10 | 2024 | 325 | 0.520 |
Why?
| | Health Status | 1 | 2023 | 822 | 0.520 |
Why?
| | Linear Models | 4 | 2019 | 847 | 0.490 |
Why?
| | Genetic Predisposition to Disease | 12 | 2025 | 2455 | 0.490 |
Why?
| | Female | 68 | 2026 | 79080 | 0.480 |
Why?
| | Models, Theoretical | 1 | 2020 | 558 | 0.480 |
Why?
| | ROC Curve | 5 | 2020 | 613 | 0.480 |
Why?
| | Case-Control Studies | 16 | 2026 | 3633 | 0.460 |
Why?
| | Hypnotics and Sedatives | 1 | 2018 | 221 | 0.460 |
Why?
| | Alcoholism | 3 | 2020 | 830 | 0.450 |
Why?
| | Animals | 34 | 2023 | 38030 | 0.450 |
Why?
| | Glycosphingolipids | 1 | 2015 | 7 | 0.440 |
Why?
| | Seroconversion | 3 | 2026 | 48 | 0.430 |
Why?
| | Environmental Pollutants | 3 | 2023 | 142 | 0.430 |
Why?
| | CpG Islands | 7 | 2024 | 175 | 0.420 |
Why?
| | Drosophila | 3 | 2010 | 168 | 0.420 |
Why?
| | Placenta | 5 | 2023 | 794 | 0.400 |
Why?
| | Interleukin-16 | 1 | 2013 | 6 | 0.400 |
Why?
| | Pregnancy | 22 | 2025 | 7217 | 0.400 |
Why?
| | HIV-1 | 4 | 2026 | 911 | 0.400 |
Why?
| | Nitrogenase | 2 | 2013 | 11 | 0.400 |
Why?
| | Smoking Cessation | 1 | 2017 | 440 | 0.380 |
Why?
| | Male | 54 | 2026 | 73014 | 0.380 |
Why?
| | Transcription, Genetic | 3 | 2018 | 1429 | 0.380 |
Why?
| | Schistosomiasis japonica | 3 | 2022 | 37 | 0.380 |
Why?
| | Markov Chains | 2 | 2020 | 128 | 0.370 |
Why?
| | Multivariate Analysis | 2 | 2013 | 1531 | 0.370 |
Why?
| | Mice | 19 | 2022 | 18266 | 0.370 |
Why?
| | Interferon-alpha | 2 | 2026 | 201 | 0.370 |
Why?
| | DNA | 3 | 2019 | 1418 | 0.370 |
Why?
| | Sample Size | 3 | 2023 | 123 | 0.360 |
Why?
| | Genotype | 6 | 2020 | 1866 | 0.360 |
Why?
| | Diabetes, Gestational | 3 | 2023 | 307 | 0.360 |
Why?
| | RNA, Messenger | 7 | 2023 | 2783 | 0.350 |
Why?
| | Child | 31 | 2026 | 22638 | 0.350 |
Why?
| | Transcription Factors | 6 | 2024 | 1728 | 0.340 |
Why?
| | Phylogeny | 2 | 2013 | 921 | 0.340 |
Why?
| | Lipid Metabolism | 4 | 2024 | 533 | 0.340 |
Why?
| | Schistosoma japonicum | 2 | 2022 | 36 | 0.330 |
Why?
| | Support Vector Machine | 2 | 2021 | 33 | 0.320 |
Why?
| | Child, Preschool | 20 | 2026 | 11888 | 0.320 |
Why?
| | Bias | 2 | 2022 | 196 | 0.320 |
Why?
| | Area Under Curve | 3 | 2020 | 333 | 0.320 |
Why?
| | Lung | 5 | 2023 | 4119 | 0.310 |
Why?
| | Genome, Human | 3 | 2019 | 425 | 0.310 |
Why?
| | Molybdoferredoxin | 1 | 2009 | 13 | 0.300 |
Why?
| | Binding Sites | 5 | 2021 | 1306 | 0.300 |
Why?
| | Leukocytes, Mononuclear | 4 | 2026 | 585 | 0.300 |
Why?
| | Autoantibodies | 5 | 2026 | 1498 | 0.290 |
Why?
| | HIV Infections | 5 | 2026 | 3210 | 0.290 |
Why?
| | Disease Progression | 6 | 2026 | 2857 | 0.290 |
Why?
| | Gastrointestinal Tract | 2 | 2022 | 203 | 0.280 |
Why?
| | Signal Transduction | 8 | 2026 | 5234 | 0.280 |
Why?
| | Oxidoreductases | 1 | 2009 | 91 | 0.280 |
Why?
| | Infant, Newborn | 15 | 2024 | 6449 | 0.270 |
Why?
| | Adiponectin | 2 | 2024 | 243 | 0.270 |
Why?
| | Mycobacterium tuberculosis | 3 | 2016 | 325 | 0.270 |
Why?
| | Insulin | 6 | 2023 | 2524 | 0.260 |
Why?
| | Cohort Studies | 11 | 2026 | 6045 | 0.260 |
Why?
| | Exons | 1 | 2008 | 361 | 0.260 |
Why?
| | Insulin-Like Growth Factor I | 2 | 2021 | 318 | 0.250 |
Why?
| | Bronchoalveolar Lavage Fluid | 2 | 2022 | 641 | 0.250 |
Why?
| | Cluster Analysis | 3 | 2024 | 494 | 0.240 |
Why?
| | Mucin-1 | 1 | 2026 | 29 | 0.240 |
Why?
| | Alternative Splicing | 1 | 2008 | 249 | 0.240 |
Why?
| | Mice, Inbred DBA | 2 | 2019 | 185 | 0.240 |
Why?
| | Alcohol Drinking | 5 | 2014 | 847 | 0.230 |
Why?
| | Environmental Exposure | 2 | 2020 | 578 | 0.220 |
Why?
| | Alkanesulfonic Acids | 2 | 2023 | 37 | 0.220 |
Why?
| | Middle Aged | 19 | 2026 | 36359 | 0.220 |
Why?
| | Genome | 3 | 2013 | 307 | 0.220 |
Why?
| | Principal Component Analysis | 2 | 2023 | 192 | 0.220 |
Why?
| | Tuberculosis | 2 | 2020 | 289 | 0.210 |
Why?
| | Nasal Mucosa | 1 | 2025 | 112 | 0.210 |
Why?
| | Tuberculosis, Pulmonary | 2 | 2016 | 127 | 0.210 |
Why?
| | Soot | 1 | 2024 | 23 | 0.210 |
Why?
| | Mice, Inbred Strains | 4 | 2020 | 384 | 0.210 |
Why?
| | Quantitative Trait, Heritable | 3 | 2017 | 118 | 0.210 |
Why?
| | Oxylipins | 2 | 2023 | 47 | 0.210 |
Why?
| | CD4-Positive T-Lymphocytes | 3 | 2026 | 1148 | 0.210 |
Why?
| | Aged | 14 | 2026 | 26251 | 0.210 |
Why?
| | Melanocytes | 2 | 2015 | 57 | 0.200 |
Why?
| | Carnitine O-Palmitoyltransferase | 2 | 2021 | 49 | 0.200 |
Why?
| | Prospective Studies | 9 | 2023 | 8087 | 0.200 |
Why?
| | Severity of Illness Index | 5 | 2021 | 2910 | 0.200 |
Why?
| | Adolescent | 14 | 2026 | 22451 | 0.200 |
Why?
| | Reproducibility of Results | 3 | 2021 | 3396 | 0.190 |
Why?
| | Body Mass Index | 5 | 2024 | 2446 | 0.190 |
Why?
| | Sequence Analysis, DNA | 2 | 2019 | 771 | 0.190 |
Why?
| | Diet | 2 | 2021 | 1271 | 0.190 |
Why?
| | Genetic Association Studies | 3 | 2020 | 376 | 0.190 |
Why?
| | Mice, Inbred C57BL | 5 | 2019 | 6021 | 0.190 |
Why?
| | Genetic Variation | 3 | 2024 | 992 | 0.190 |
Why?
| | Infant | 12 | 2024 | 10093 | 0.190 |
Why?
| | Vitamin D | 1 | 2026 | 402 | 0.180 |
Why?
| | Birth Weight | 3 | 2023 | 521 | 0.180 |
Why?
| | Somatic Hypermutation, Immunoglobulin | 1 | 2022 | 19 | 0.180 |
Why?
| | Phospholipids | 2 | 2021 | 215 | 0.180 |
Why?
| | Asthma | 2 | 2025 | 1800 | 0.180 |
Why?
| | Longitudinal Studies | 7 | 2026 | 3005 | 0.180 |
Why?
| | Bone Morphogenetic Proteins | 1 | 2023 | 143 | 0.180 |
Why?
| | Neutrophils | 2 | 2026 | 1132 | 0.180 |
Why?
| | Mothers | 3 | 2023 | 771 | 0.180 |
Why?
| | Schistosomiasis | 1 | 2022 | 53 | 0.170 |
Why?
| | Air Pollutants | 2 | 2024 | 406 | 0.170 |
Why?
| | Epidemiologic Studies | 1 | 2021 | 70 | 0.170 |
Why?
| | Selection Bias | 1 | 2021 | 38 | 0.170 |
Why?
| | Endemic Diseases | 1 | 2021 | 33 | 0.170 |
Why?
| | Viral Nonstructural Proteins | 1 | 2021 | 64 | 0.170 |
Why?
| | Breast Neoplasms | 3 | 2019 | 2411 | 0.170 |
Why?
| | Cloud Computing | 1 | 2021 | 6 | 0.170 |
Why?
| | 11-beta-Hydroxysteroid Dehydrogenase Type 2 | 1 | 2021 | 10 | 0.170 |
Why?
| | Receptor for Advanced Glycation End Products | 1 | 2021 | 36 | 0.170 |
Why?
| | Mitogen-Activated Protein Kinase 9 | 1 | 2021 | 17 | 0.160 |
Why?
| | Immunoglobulin A | 1 | 2022 | 205 | 0.160 |
Why?
| | Adult | 21 | 2026 | 40821 | 0.160 |
Why?
| | Central Nervous System Depressants | 2 | 2012 | 83 | 0.160 |
Why?
| | Sensitivity and Specificity | 2 | 2017 | 1992 | 0.160 |
Why?
| | Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha | 1 | 2021 | 39 | 0.160 |
Why?
| | Normal Distribution | 2 | 2018 | 22 | 0.160 |
Why?
| | Polyadenylation | 1 | 2021 | 41 | 0.160 |
Why?
| | Spike Glycoprotein, Coronavirus | 1 | 2021 | 129 | 0.160 |
Why?
| | Mutation | 3 | 2021 | 4082 | 0.160 |
Why?
| | B-Lymphocytes | 1 | 2026 | 884 | 0.160 |
Why?
| | Population Dynamics | 1 | 2021 | 142 | 0.160 |
Why?
| | Biostatistics | 1 | 2020 | 19 | 0.160 |
Why?
| | Probability | 1 | 2021 | 308 | 0.160 |
Why?
| | Drug Tolerance | 1 | 2020 | 99 | 0.160 |
Why?
| | Travel | 1 | 2021 | 133 | 0.160 |
Why?
| | Predictive Value of Tests | 4 | 2026 | 2097 | 0.160 |
Why?
| | Interferon-beta | 1 | 2020 | 90 | 0.150 |
Why?
| | Monte Carlo Method | 1 | 2020 | 150 | 0.150 |
Why?
| | Discriminant Analysis | 1 | 2020 | 35 | 0.150 |
Why?
| | Genome, Viral | 1 | 2021 | 217 | 0.150 |
Why?
| | Least-Squares Analysis | 1 | 2020 | 73 | 0.150 |
Why?
| | Smoke | 2 | 2023 | 149 | 0.150 |
Why?
| | AMP-Activated Protein Kinases | 2 | 2020 | 192 | 0.150 |
Why?
| | Decision Trees | 1 | 2020 | 75 | 0.150 |
Why?
| | p38 Mitogen-Activated Protein Kinases | 1 | 2021 | 262 | 0.150 |
Why?
| | Whole Genome Sequencing | 1 | 2021 | 183 | 0.150 |
Why?
| | Infant Nutritional Physiological Phenomena | 1 | 2021 | 159 | 0.150 |
Why?
| | Premature Birth | 1 | 2023 | 389 | 0.150 |
Why?
| | Risk Factors | 8 | 2024 | 10840 | 0.150 |
Why?
| | Liver | 2 | 2019 | 1859 | 0.150 |
Why?
| | Atherosclerosis | 1 | 2023 | 410 | 0.150 |
Why?
| | alpha-Macroglobulins | 1 | 2019 | 24 | 0.150 |
Why?
| | Child Nutritional Physiological Phenomena | 1 | 2019 | 102 | 0.140 |
Why?
| | Rats | 4 | 2023 | 5574 | 0.140 |
Why?
| | Base Sequence | 3 | 2021 | 2119 | 0.140 |
Why?
| | Air Pollution | 1 | 2022 | 314 | 0.140 |
Why?
| | Sex Characteristics | 2 | 2023 | 798 | 0.140 |
Why?
| | Hypertension, Pregnancy-Induced | 1 | 2019 | 69 | 0.140 |
Why?
| | GABA-A Receptor Antagonists | 1 | 2018 | 19 | 0.140 |
Why?
| | Reflex, Righting | 1 | 2018 | 15 | 0.140 |
Why?
| | Proteome | 1 | 2023 | 520 | 0.140 |
Why?
| | Autism Spectrum Disorder | 1 | 2023 | 404 | 0.140 |
Why?
| | Marijuana Use | 1 | 2022 | 218 | 0.130 |
Why?
| | Antiviral Agents | 2 | 2021 | 774 | 0.130 |
Why?
| | Receptor, Insulin | 1 | 2017 | 92 | 0.130 |
Why?
| | Papillomavirus E7 Proteins | 1 | 2017 | 11 | 0.130 |
Why?
| | Respiratory Mucosa | 1 | 2020 | 323 | 0.130 |
Why?
| | Non-alcoholic Fatty Liver Disease | 1 | 2020 | 265 | 0.130 |
Why?
| | Alcohol-Related Disorders | 1 | 2018 | 125 | 0.130 |
Why?
| | Epigenomics | 2 | 2018 | 123 | 0.120 |
Why?
| | Dendritic Cells | 1 | 2020 | 507 | 0.120 |
Why?
| | Receptors, GABA-A | 1 | 2018 | 138 | 0.120 |
Why?
| | Down-Regulation | 1 | 2019 | 612 | 0.120 |
Why?
| | Chemokines | 1 | 2017 | 217 | 0.120 |
Why?
| | Otitis Media | 1 | 2019 | 178 | 0.120 |
Why?
| | Forced Expiratory Volume | 3 | 2026 | 451 | 0.120 |
Why?
| | Alleles | 1 | 2019 | 900 | 0.120 |
Why?
| | Keratinocytes | 1 | 2017 | 190 | 0.120 |
Why?
| | Longevity | 1 | 2017 | 179 | 0.120 |
Why?
| | DNA-Binding Proteins | 3 | 2019 | 1467 | 0.120 |
Why?
| | Rural Population | 1 | 2021 | 673 | 0.120 |
Why?
| | Follow-Up Studies | 5 | 2026 | 5397 | 0.120 |
Why?
| | Receptors, N-Methyl-D-Aspartate | 1 | 2018 | 233 | 0.120 |
Why?
| | Gene-Environment Interaction | 1 | 2017 | 188 | 0.120 |
Why?
| | Age Factors | 2 | 2021 | 3321 | 0.110 |
Why?
| | Pregnancy Outcome | 1 | 2019 | 502 | 0.110 |
Why?
| | High Fructose Corn Syrup | 1 | 2015 | 9 | 0.110 |
Why?
| | Biomedical Research | 2 | 2020 | 724 | 0.110 |
Why?
| | Histocompatibility Antigens Class I | 1 | 2017 | 207 | 0.110 |
Why?
| | Databases, Genetic | 2 | 2021 | 239 | 0.110 |
Why?
| | Corpus Luteum | 1 | 2015 | 23 | 0.110 |
Why?
| | Plasma | 1 | 2017 | 222 | 0.110 |
Why?
| | Calcium-Calmodulin-Dependent Protein Kinase Type 2 | 1 | 2018 | 199 | 0.110 |
Why?
| | Cell-Derived Microparticles | 1 | 2016 | 73 | 0.110 |
Why?
| | Granulosa Cells | 1 | 2015 | 37 | 0.110 |
Why?
| | Ultraviolet Therapy | 1 | 2015 | 13 | 0.110 |
Why?
| | Trihexosylceramides | 1 | 2015 | 4 | 0.110 |
Why?
| | Tobacco Products | 1 | 2016 | 90 | 0.110 |
Why?
| | Sphingomyelins | 1 | 2015 | 22 | 0.110 |
Why?
| | Adaptation, Physiological | 2 | 2016 | 567 | 0.110 |
Why?
| | Vitiligo | 1 | 2015 | 34 | 0.110 |
Why?
| | Tobacco Smoke Pollution | 1 | 2017 | 227 | 0.110 |
Why?
| | Microarray Analysis | 2 | 2012 | 117 | 0.110 |
Why?
| | Molecular Sequence Data | 2 | 2009 | 2835 | 0.110 |
Why?
| | Cannabis | 1 | 2022 | 519 | 0.110 |
Why?
| | Infant, Premature | 1 | 2019 | 622 | 0.100 |
Why?
| | Blood Proteins | 1 | 2016 | 239 | 0.100 |
Why?
| | Obesity | 4 | 2023 | 3123 | 0.100 |
Why?
| | Hair | 1 | 2015 | 81 | 0.100 |
Why?
| | Databases, Nucleic Acid | 1 | 2014 | 39 | 0.100 |
Why?
| | Hypertension, Pulmonary | 1 | 2026 | 1957 | 0.100 |
Why?
| | Child Development | 1 | 2019 | 481 | 0.100 |
Why?
| | Fatty Acids | 1 | 2017 | 460 | 0.100 |
Why?
| | Aged, 80 and over | 8 | 2021 | 8351 | 0.100 |
Why?
| | Epithelial Cells | 1 | 2020 | 1118 | 0.100 |
Why?
| | STAT2 Transcription Factor | 1 | 2013 | 3 | 0.100 |
Why?
| | 3' Untranslated Regions | 1 | 2014 | 152 | 0.100 |
Why?
| | Species Specificity | 2 | 2012 | 542 | 0.100 |
Why?
| | CCCTC-Binding Factor | 1 | 2013 | 12 | 0.100 |
Why?
| | Drug Resistance, Bacterial | 1 | 2015 | 185 | 0.100 |
Why?
| | Gastrointestinal Microbiome | 1 | 2022 | 767 | 0.100 |
Why?
| | Gangliosides | 1 | 2013 | 23 | 0.100 |
Why?
| | Saccharomyces | 1 | 2013 | 6 | 0.100 |
Why?
| | G-Quadruplexes | 1 | 2013 | 23 | 0.100 |
Why?
| | Caloric Restriction | 1 | 2015 | 133 | 0.100 |
Why?
| | Microbiota | 1 | 2021 | 724 | 0.100 |
Why?
| | Dietary Fats | 1 | 2015 | 307 | 0.100 |
Why?
| | Myocardium | 1 | 2018 | 948 | 0.090 |
Why?
| | Choice Behavior | 1 | 2014 | 179 | 0.090 |
Why?
| | Antitubercular Agents | 1 | 2015 | 211 | 0.090 |
Why?
| | Sequence Alignment | 1 | 2013 | 360 | 0.090 |
Why?
| | DNA Probes | 1 | 2012 | 57 | 0.090 |
Why?
| | Programming Languages | 1 | 2012 | 24 | 0.090 |
Why?
| | Gene Expression Regulation, Bacterial | 1 | 2015 | 337 | 0.090 |
Why?
| | Heat-Shock Proteins | 1 | 2013 | 140 | 0.090 |
Why?
| | Young Adult | 8 | 2026 | 14240 | 0.090 |
Why?
| | Tretinoin | 1 | 2013 | 114 | 0.090 |
Why?
| | Gene Expression Regulation, Neoplastic | 1 | 2018 | 1429 | 0.090 |
Why?
| | Ultraviolet Rays | 1 | 2015 | 376 | 0.090 |
Why?
| | Teratogens | 1 | 2012 | 25 | 0.090 |
Why?
| | Proportional Hazards Models | 3 | 2021 | 1318 | 0.090 |
Why?
| | Age of Onset | 2 | 2026 | 557 | 0.090 |
Why?
| | Weight Gain | 1 | 2015 | 561 | 0.080 |
Why?
| | Fetal Alcohol Spectrum Disorders | 1 | 2012 | 74 | 0.080 |
Why?
| | Protein Binding | 2 | 2021 | 2239 | 0.080 |
Why?
| | Regression Analysis | 3 | 2021 | 994 | 0.080 |
Why?
| | Tomography, X-Ray Computed | 3 | 2021 | 2766 | 0.080 |
Why?
| | China | 2 | 2022 | 278 | 0.080 |
Why?
| | Triglycerides | 2 | 2023 | 527 | 0.080 |
Why?
| | Chromosome Mapping | 3 | 2020 | 505 | 0.080 |
Why?
| | Body Weight | 1 | 2015 | 964 | 0.080 |
Why?
| | Pain Threshold | 1 | 2010 | 72 | 0.080 |
Why?
| | HLA-DR4 Antigen | 2 | 2021 | 74 | 0.080 |
Why?
| | Stem Cells | 1 | 2015 | 612 | 0.080 |
Why?
| | HLA-DR3 Antigen | 2 | 2021 | 76 | 0.080 |
Why?
| | Dysbiosis | 2 | 2022 | 184 | 0.080 |
Why?
| | Adrenal Cortex Hormones | 1 | 2013 | 483 | 0.080 |
Why?
| | Repressor Proteins | 1 | 2013 | 428 | 0.080 |
Why?
| | Gene Expression Regulation, Developmental | 2 | 2012 | 899 | 0.080 |
Why?
| | Cytokines | 1 | 2017 | 2079 | 0.070 |
Why?
| | Amino Acid Sequence | 2 | 2013 | 2088 | 0.070 |
Why?
| | Morphine | 1 | 2010 | 169 | 0.070 |
Why?
| | Hedgehog Proteins | 1 | 2010 | 194 | 0.070 |
Why?
| | Analysis of Variance | 1 | 2012 | 1293 | 0.070 |
Why?
| | Internet | 2 | 2010 | 656 | 0.070 |
Why?
| | Polymerase Chain Reaction | 1 | 2012 | 1030 | 0.070 |
Why?
| | Vital Capacity | 2 | 2021 | 293 | 0.070 |
Why?
| | Spirometry | 2 | 2021 | 234 | 0.070 |
Why?
| | Energy Metabolism | 1 | 2015 | 930 | 0.070 |
Why?
| | Yeasts | 1 | 2008 | 54 | 0.070 |
Why?
| | Drosophila Proteins | 1 | 2010 | 207 | 0.070 |
Why?
| | Fasting | 2 | 2023 | 280 | 0.070 |
Why?
| | Synaptic Transmission | 1 | 2010 | 292 | 0.070 |
Why?
| | Food Preferences | 1 | 2009 | 126 | 0.070 |
Why?
| | Gestational Age | 2 | 2023 | 989 | 0.070 |
Why?
| | Glycerophospholipids | 2 | 2018 | 39 | 0.070 |
Why?
| | RNA Precursors | 1 | 2008 | 155 | 0.060 |
Why?
| | Enhancer Elements, Genetic | 1 | 2008 | 190 | 0.060 |
Why?
| | Prognosis | 2 | 2026 | 4331 | 0.060 |
Why?
| | Gene Ontology | 2 | 2017 | 55 | 0.060 |
Why?
| | Folic Acid | 2 | 2019 | 197 | 0.060 |
Why?
| | Tandem Mass Spectrometry | 2 | 2021 | 574 | 0.060 |
Why?
| | Phosphorylation | 2 | 2021 | 1717 | 0.060 |
Why?
| | Uganda | 2 | 2016 | 91 | 0.060 |
Why?
| | Glucose | 2 | 2023 | 1051 | 0.050 |
Why?
| | Neoplasms | 2 | 2018 | 2944 | 0.050 |
Why?
| | Apoptosis | 1 | 2013 | 2436 | 0.050 |
Why?
| | Sputum | 2 | 2016 | 302 | 0.050 |
Why?
| | Alkanesulfonates | 1 | 2023 | 6 | 0.050 |
Why?
| | GTPase-Activating Proteins | 1 | 2023 | 81 | 0.050 |
Why?
| | Carboxylic Acids | 1 | 2023 | 31 | 0.050 |
Why?
| | Adipogenesis | 1 | 2023 | 56 | 0.050 |
Why?
| | Hypertrophy | 1 | 2023 | 126 | 0.050 |
Why?
| | Privacy | 1 | 2023 | 41 | 0.050 |
Why?
| | Cell Proliferation | 3 | 2015 | 2497 | 0.050 |
Why?
| | Models, Neurological | 1 | 2024 | 252 | 0.050 |
Why?
| | Schistosoma | 1 | 2022 | 29 | 0.040 |
Why?
| | Snails | 1 | 2022 | 40 | 0.040 |
Why?
| | Pneumonia | 2 | 2020 | 633 | 0.040 |
Why?
| | Benchmarking | 1 | 2023 | 192 | 0.040 |
Why?
| | Protein Conformation, beta-Strand | 1 | 2021 | 18 | 0.040 |
Why?
| | Cell Differentiation | 2 | 2023 | 1979 | 0.040 |
Why?
| | Protein Conformation, alpha-Helical | 1 | 2021 | 18 | 0.040 |
Why?
| | Furin | 1 | 2021 | 12 | 0.040 |
Why?
| | Asia | 1 | 2021 | 69 | 0.040 |
Why?
| | Analgesics, Opioid | 1 | 2010 | 1158 | 0.040 |
Why?
| | Adipocytes | 1 | 2023 | 223 | 0.040 |
Why?
| | Granzymes | 1 | 2022 | 51 | 0.040 |
Why?
| | Water Resources | 1 | 2021 | 8 | 0.040 |
Why?
| | Africa | 1 | 2021 | 119 | 0.040 |
Why?
| | Nerve Net | 1 | 2024 | 284 | 0.040 |
Why?
| | Immunity, Humoral | 1 | 2022 | 121 | 0.040 |
Why?
| | Molecular Docking Simulation | 1 | 2021 | 120 | 0.040 |
Why?
| | Epidemiological Monitoring | 1 | 2021 | 70 | 0.040 |
Why?
| | Receptor-Like Protein Tyrosine Phosphatases, Class 8 | 1 | 2021 | 54 | 0.040 |
Why?
| | Linoleic Acid | 1 | 2021 | 44 | 0.040 |
Why?
| | Cholesterol | 1 | 2023 | 410 | 0.040 |
Why?
| | Arachidonic Acid | 1 | 2021 | 101 | 0.040 |
Why?
| | Protein Interaction Domains and Motifs | 1 | 2021 | 144 | 0.040 |
Why?
| | Adenosine Monophosphate | 1 | 2021 | 87 | 0.040 |
Why?
| | Amino Acid Substitution | 1 | 2021 | 295 | 0.040 |
Why?
| | Europe | 1 | 2021 | 420 | 0.040 |
Why?
| | Glutamate Decarboxylase | 1 | 2021 | 166 | 0.040 |
Why?
| | Alanine | 1 | 2021 | 171 | 0.040 |
Why?
| | Sex Factors | 2 | 2019 | 2101 | 0.040 |
Why?
| | Interleukin-2 | 1 | 2022 | 434 | 0.040 |
Why?
| | Docosahexaenoic Acids | 1 | 2021 | 90 | 0.040 |
Why?
| | Systems Biology | 1 | 2021 | 68 | 0.040 |
Why?
| | Skinfold Thickness | 1 | 2020 | 43 | 0.040 |
Why?
| | Datasets as Topic | 1 | 2020 | 120 | 0.040 |
Why?
| | Cattle | 1 | 2022 | 938 | 0.040 |
Why?
| | Nerve Tissue Proteins | 1 | 2023 | 594 | 0.040 |
Why?
| | Swine | 1 | 2022 | 821 | 0.040 |
Why?
| | Particulate Matter | 1 | 2022 | 328 | 0.040 |
Why?
| | Philippines | 1 | 2019 | 50 | 0.040 |
Why?
| | Workflow | 1 | 2021 | 181 | 0.040 |
Why?
| | Finland | 1 | 2019 | 72 | 0.040 |
Why?
| | Pakistan | 1 | 2019 | 83 | 0.040 |
Why?
| | Endoplasmic Reticulum Stress | 1 | 2020 | 120 | 0.040 |
Why?
| | Colon | 1 | 2022 | 304 | 0.040 |
Why?
| | In Vitro Techniques | 1 | 2021 | 1041 | 0.040 |
Why?
| | Bronchoscopy | 1 | 2020 | 227 | 0.040 |
Why?
| | Chromatography, High Pressure Liquid | 1 | 2021 | 588 | 0.040 |
Why?
| | Water | 1 | 2022 | 451 | 0.040 |
Why?
| | Cigarette Smoking | 1 | 2020 | 103 | 0.030 |
Why?
| | Gene Frequency | 1 | 2020 | 495 | 0.030 |
Why?
| | Early Diagnosis | 1 | 2019 | 249 | 0.030 |
Why?
| | Computer Graphics | 1 | 2018 | 41 | 0.030 |
Why?
| | Interleukins | 1 | 2020 | 247 | 0.030 |
Why?
| | Cross-Sectional Studies | 2 | 2022 | 5875 | 0.030 |
Why?
| | Environmental Pollution | 1 | 2018 | 21 | 0.030 |
Why?
| | Community-Acquired Infections | 1 | 2020 | 179 | 0.030 |
Why?
| | Leptin | 1 | 2019 | 247 | 0.030 |
Why?
| | Diabetes Mellitus, Type 2 | 2 | 2023 | 2623 | 0.030 |
Why?
| | Pedigree | 1 | 2019 | 507 | 0.030 |
Why?
| | Adaptor Proteins, Vesicular Transport | 1 | 2018 | 46 | 0.030 |
Why?
| | Acetyl-CoA Carboxylase | 1 | 2017 | 32 | 0.030 |
Why?
| | Breast Feeding | 1 | 2021 | 447 | 0.030 |
Why?
| | Evolution, Molecular | 1 | 2021 | 501 | 0.030 |
Why?
| | Maternal Health | 1 | 2018 | 50 | 0.030 |
Why?
| | Cell Transformation, Viral | 1 | 2017 | 23 | 0.030 |
Why?
| | Caprylates | 1 | 2017 | 21 | 0.030 |
Why?
| | Collagen | 1 | 2020 | 460 | 0.030 |
Why?
| | Epistasis, Genetic | 1 | 2017 | 66 | 0.030 |
Why?
| | Umbilical Cord | 1 | 2017 | 92 | 0.030 |
Why?
| | United States | 3 | 2021 | 16041 | 0.030 |
Why?
| | Neoplasm Proteins | 1 | 2020 | 443 | 0.030 |
Why?
| | Gambia | 1 | 2016 | 8 | 0.030 |
Why?
| | Muscle Development | 1 | 2017 | 114 | 0.030 |
Why?
| | Time Factors | 2 | 2021 | 7079 | 0.030 |
Why?
| | THP-1 Cells | 1 | 2016 | 19 | 0.030 |
Why?
| | TOR Serine-Threonine Kinases | 1 | 2020 | 454 | 0.030 |
Why?
| | Rats, Inbred SHR | 1 | 2016 | 36 | 0.030 |
Why?
| | Lod Score | 1 | 2016 | 62 | 0.030 |
Why?
| | Regulon | 1 | 2016 | 34 | 0.030 |
Why?
| | Immunity, Innate | 1 | 2022 | 843 | 0.030 |
Why?
| | Nitrogen Oxides | 1 | 2016 | 46 | 0.030 |
Why?
| | Actins | 1 | 2018 | 422 | 0.030 |
Why?
| | Child Health | 1 | 2018 | 152 | 0.030 |
Why?
| | Antigen Presentation | 1 | 2017 | 209 | 0.030 |
Why?
| | Bacteria | 1 | 2022 | 766 | 0.030 |
Why?
| | Granuloma | 1 | 2016 | 96 | 0.030 |
Why?
| | Logistic Models | 1 | 2021 | 2112 | 0.030 |
Why?
| | ABO Blood-Group System | 1 | 2016 | 56 | 0.030 |
Why?
| | Fetal Development | 1 | 2019 | 296 | 0.030 |
Why?
| | Linkage Disequilibrium | 1 | 2016 | 257 | 0.030 |
Why?
| | Insulin Resistance | 1 | 2024 | 1247 | 0.030 |
Why?
| | Follicular Phase | 1 | 2015 | 41 | 0.030 |
Why?
| | Ovulation | 1 | 2015 | 46 | 0.030 |
Why?
| | PAX3 Transcription Factor | 1 | 2015 | 16 | 0.030 |
Why?
| | Caenorhabditis elegans Proteins | 1 | 2017 | 208 | 0.030 |
Why?
| | Mice, Congenic | 1 | 2015 | 23 | 0.030 |
Why?
| | Paired Box Transcription Factors | 1 | 2015 | 42 | 0.030 |
Why?
| | Molecular Sequence Annotation | 1 | 2015 | 110 | 0.030 |
Why?
| | Hair Follicle | 1 | 2015 | 35 | 0.030 |
Why?
| | Intramolecular Oxidoreductases | 1 | 2015 | 64 | 0.030 |
Why?
| | Immune System | 1 | 2016 | 181 | 0.030 |
Why?
| | Prevalence | 1 | 2022 | 2852 | 0.030 |
Why?
| | Epidermis | 1 | 2015 | 72 | 0.030 |
Why?
| | Latent Tuberculosis | 1 | 2015 | 70 | 0.030 |
Why?
| | Proto-Oncogene Proteins c-kit | 1 | 2015 | 73 | 0.030 |
Why?
| | Monocytes | 1 | 2017 | 538 | 0.030 |
Why?
| | Heart | 1 | 2018 | 624 | 0.030 |
Why?
| | Mortality | 1 | 2017 | 375 | 0.030 |
Why?
| | Breeding | 1 | 2014 | 64 | 0.030 |
Why?
| | Gastroesophageal Reflux | 1 | 2017 | 232 | 0.030 |
Why?
| | Fetus | 1 | 2019 | 798 | 0.030 |
Why?
| | Protein Kinases | 1 | 2016 | 311 | 0.030 |
Why?
| | Caenorhabditis elegans | 1 | 2017 | 329 | 0.030 |
Why?
| | Diet, High-Fat | 1 | 2015 | 267 | 0.020 |
Why?
| | Monophenol Monooxygenase | 1 | 2013 | 7 | 0.020 |
Why?
| | Oxidation-Reduction | 1 | 2017 | 1075 | 0.020 |
Why?
| | Microscopy, Phase-Contrast | 1 | 2013 | 17 | 0.020 |
Why?
| | Annexin A5 | 1 | 2013 | 23 | 0.020 |
Why?
| | Melanins | 1 | 2013 | 15 | 0.020 |
Why?
| | Education | 1 | 2013 | 102 | 0.020 |
Why?
| | Spectrophotometry | 1 | 2013 | 58 | 0.020 |
Why?
| | Catalase | 1 | 2013 | 133 | 0.020 |
Why?
| | Administration, Topical | 1 | 2013 | 153 | 0.020 |
Why?
| | Sequence Homology, Amino Acid | 1 | 2013 | 382 | 0.020 |
Why?
| | Pilot Projects | 1 | 2018 | 1878 | 0.020 |
Why?
| | Blood Glucose | 1 | 2023 | 2357 | 0.020 |
Why?
| | Statistics, Nonparametric | 1 | 2013 | 423 | 0.020 |
Why?
| | Real-Time Polymerase Chain Reaction | 1 | 2013 | 333 | 0.020 |
Why?
| | Promoter Regions, Genetic | 1 | 2017 | 1236 | 0.020 |
Why?
| | Structure-Activity Relationship | 1 | 2013 | 561 | 0.020 |
Why?
| | Neoplasm Metastasis | 1 | 2014 | 693 | 0.020 |
Why?
| | Superoxide Dismutase | 1 | 2013 | 307 | 0.020 |
Why?
| | Urinary Bladder Neoplasms | 1 | 2014 | 257 | 0.020 |
Why?
| | GTP-Binding Protein beta Subunits | 1 | 2010 | 17 | 0.020 |
Why?
| | Receptors, GABA | 1 | 2010 | 13 | 0.020 |
Why?
| | Genetics, Behavioral | 1 | 2010 | 17 | 0.020 |
Why?
| | Membrane Proteins | 1 | 2017 | 1130 | 0.020 |
Why?
| | Thermosensing | 1 | 2010 | 12 | 0.020 |
Why?
| | Software Design | 1 | 2010 | 25 | 0.020 |
Why?
| | Crosses, Genetic | 1 | 2010 | 120 | 0.020 |
Why?
| | Cell Movement | 1 | 2015 | 950 | 0.020 |
Why?
| | Embryo, Nonmammalian | 1 | 2010 | 171 | 0.020 |
Why?
| | Cell Survival | 1 | 2013 | 1102 | 0.020 |
Why?
| | Organ Specificity | 1 | 2010 | 306 | 0.020 |
Why?
| | Models, Biological | 1 | 2017 | 1758 | 0.020 |
Why?
| | Colorado | 1 | 2020 | 4588 | 0.020 |
Why?
| | Endothelium, Vascular | 1 | 2016 | 952 | 0.020 |
Why?
| | Rats, Inbred Strains | 1 | 2009 | 316 | 0.020 |
Why?
| | Bacterial Proteins | 1 | 2016 | 976 | 0.020 |
Why?
| | Antioxidants | 1 | 2013 | 544 | 0.020 |
Why?
| | Brain Chemistry | 1 | 2009 | 121 | 0.020 |
Why?
| | gamma-Aminobutyric Acid | 1 | 2010 | 195 | 0.020 |
Why?
| | Hypoxia | 1 | 2016 | 1209 | 0.020 |
Why?
| | Macrophages | 1 | 2016 | 1530 | 0.020 |
Why?
| | Models, Molecular | 1 | 2013 | 1571 | 0.020 |
Why?
| | Histones | 1 | 2013 | 670 | 0.020 |
Why?
| | Surveys and Questionnaires | 1 | 2020 | 6050 | 0.020 |
Why?
| | Brain Mapping | 1 | 2010 | 540 | 0.020 |
Why?
| | Curriculum | 1 | 2013 | 1074 | 0.020 |
Why?
| | Cell Line, Tumor | 1 | 2014 | 3538 | 0.010 |
Why?
| | Cells, Cultured | 1 | 2013 | 4112 | 0.010 |
Why?
| | Antineoplastic Agents | 1 | 2014 | 2218 | 0.010 |
Why?
| | Disease Models, Animal | 1 | 2009 | 4565 | 0.010 |
Why?
| | Retrospective Studies | 1 | 2017 | 17291 | 0.010 |
Why?
|
|
Kechris's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|